We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Serotonin-Deficient Mice Reveal Molecular Basis for Drug Abuse

By Biotechdaily staff writers
Posted on 10 Sep 2007
Neurologic researchers have shown that it is possible to dissociate the beneficial analgesic effects of opiate drugs such as morphine from unwanted side effects such as tolerance, abuse, and addiction.

The key to determining the link between pain relief and addiction is the chemical compound serotonin (5-hydroxytryptamine or 5-HT). More...
Although only 1% of the body's total 5-HT occurs in the brain, it is here that the actions of this substance are the most profound. The neurons containing 5-HT are concentrated in the raphe nuclei in the mid-brain, and their fibers project in a diffuse way to the cerebral cortex, hippocampus, limbic system, and hypothalamus as well as down the spinal cord. Changes in serotonin levels can alter mood: increases have a calming effect, relieving depression, insomnia, and irritability; decreases are associated with wakefulness and greater sensitivity to pain.

While mice genetically engineered to lack the Lmx1b gene that controls synthesis of serotonin have been available for several years, they die soon after birth and cannot be used for behavioral studies. However, in their paper in the August 27, 2007, online edition of the Proceedings of the [U.S.] Academy of Sciences, investigators from the Washington University School of Medicine (St. Louis, MO, USA) reported that they had created a line of mice lacking Lmx1b only in 5-HT-producing neurons. These animals lived to adulthood with apparently normal motor function.

"We performed a number of tests to measure the response of the mice to different opiate drugs,” explained senior author Dr. Zhou-Feng Chen, associate professor of anesthesiology and pharmacology at the Washington University School of Medicine. "In contrast to previous studies that used drugs to destroy or disable 5-HT neurons, our study provides the first genetic evidence to support the ‘classical' view that 5-HT neurons are a very important component of the neural circuits required for the analgesic effects of these drugs.”

Future work will focus on finding drugs that will suppress pain without risk of tolerance and drug addiction by acting on serotonergic neurons or opiate receptors on those neurons.

"These findings demonstrate that opiates exert their analgesic effects through a serotonin mechanism but that serotonin is not responsible for the negative, addictive side effects associated with those pain-killing drugs,” concluded Dr. Chen. "That was unexpected because serotonin has been known to interact with other neurotransmitters like dopamine or to modulate the levels of these neurotransmitters in the forebrain, which is important for reward-seeking behaviors.”


Related Links:
Washington University School of Medicine

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.